Several studies have shown that the expression of CD38 in tumors can induce proliferation and inhibit apoptosis (March et al., 2007) and participate in processes, such as tumor cell energy metabolism (Liao et al., 2020), and immune tolerance and resistance (Chen et al., 2018). This evidence concerns the gene CD38 and neoplasm.